Literature DB >> 1429687

Interleukin-1 alpha induces the accumulation of cytosolic phospholipase A2 and the release of prostaglandin E2 in human fibroblasts.

L L Lin1, A Y Lin, D L DeWitt.   

Abstract

Treatment of the human lung fibroblast cell line, WI-38, with interleukin-1 alpha (IL-1 alpha) results in a large increase in the production of cytosolic phospholipase A2 (cPLA2) and prostaglandin E2 (PGE2). The IL-1-induced accumulation of cPLA2 is closely correlated with increased PGE2 release. In contrast to cPLA2, the level of cyclooxygenase remains unchanged following IL-1 alpha treatment. The glucocorticoid, dexamethasone, blocks the IL-1 alpha-mediated increases in both cPLA2 and PGE2 without affecting the cyclooxygenase level. Taken together, these data suggest that in these cells, the regulation of prostaglandin production by IL-1 and glucocorticoid can be attributed to the level of cPLA2. These results provide a new mechanism for the effect of IL-1 and glucocorticoids on eicosanoid synthesis and provide additional support for an important role of cPLA2 in the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429687

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2.

Authors:  M Bustos; T M Coffman; S Saadi; J L Platt
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Differential routes of Ca2+ influx in Swiss 3T3 fibroblasts in response to receptor stimulation.

Authors:  T Miyakawa; M Kojima; M Ui
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

3.  Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis.

Authors:  S J Huterer; W W Tourtellotte; J R Wherrett
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

4.  Identifying Mechanisms of Homeostatic Signaling in Fibroblast Differentiation.

Authors:  Hayley C Warsinske; Shanna L Ashley; Jennifer J Linderman; Bethany B Moore; Denise E Kirschner
Journal:  Bull Math Biol       Date:  2015-09-18       Impact factor: 1.758

5.  Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.

Authors:  A N Fonteh; J M Samet; F H Chilton
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Molecular cloning of the 31 kDa cytosolic phospholipase A2, as an antigen recognized by the lung cancer-specific human monoclonal antibody, AE6F4.

Authors:  S Kawamoto; M Shoji; Y Setoguchi; M Kato; S Hashizume; A Ichikawa; K Osada; Y Katakura; H Tachibana; H Murakami
Journal:  Cytotechnology       Date:  1995       Impact factor: 2.058

7.  Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells.

Authors:  M Murakami; J F Penrose; Y Urade; K F Austen; J P Arm
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

8.  Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene.

Authors:  T Wu; T Ikezono; C W Angus; J H Shelhamer
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

9.  Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.

Authors:  H Kawaguchi; C C Pilbeam; S J Vargas; E E Morse; J A Lorenzo; L G Raisz
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Regulation of adhesion of AML14.3D10 cells by surface clustering of beta2-integrin caused by ERK-independent activation of cPLA2.

Authors:  Shigeharu Myou; Xiangdong Zhu; Evan Boetticher; Yimin Qin; Saori Myo; Angelo Meliton; Anissa Lambertino; Nilda M Munoz; Kimm J Hamann; Alan R Leff
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.